SNAP · Company research
Snap Inc. (SNAP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
33records availableTechnology
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Does Snap (SNAP) Stock Price Make Sense Against Its Sales? - Yahoo Finance | Does Snap (SNAP) Stock Price Make Sense Against Its Sales? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 20, 2026 | neutral | 0 | 0.6 |
| Datadog Stock Looks to Snap 5-Day Skid After Upgrade - Schaeffer's Investment Research | Datadog Stock Looks to Snap 5-Day Skid After Upgrade Schaeffer's Investment Research | View source ↗ | Schaeffer's Investment Research | Oct 19, 2026 | neutral | 0 | 0.6 |
| Can WDAY's New AI Offerings Across Business Functions Drive Growth? | Workday has introduced Decision Intelligence, an AI-powered platform that helps HR and finance teams make faster, more informed decisions by unifying workforce and financial data. The solution enables real-time analysis of costs, risks, margins, and forecasts while reducing reliance on spreadsheets. Unity Technologies has already reported benefits from using the platform for revenue variance investigation and financial reporting. | View source ↗ | Zacks Investment Research | Oct 19, 2026 | bullish | 1 | 1 |
| Should You Buy, Sell, or Hold META Stock Before Q3 Earnings Release? | Meta Platforms is set to report Q3 2026 results with expected revenues of $61B-$64B, driven by strong advertising demand and AI-powered solutions like Advantage+. However, elevated capital expenditures of $130B-$145B for 2026, margin pressure, and premium valuation remain significant concerns for investors. | View source ↗ | Zacks Investment Research | Oct 19, 2026 | neutral | -0.143 | 1 |
| SNAP Stock Jumps 7% After-Hours — Snap Beats Q2 Estimates, Issues Consensus-Beating Q3 Outlook On Ad Recovery And Subscription Growth - Stocktwits | SNAP Stock Jumps 7% After-Hours — Snap Beats Q2 Estimates, Issues Consensus-Beating Q3 Outlook On Ad Recovery And Subscription Growth Stocktwits | View source ↗ | Stocktwits | Oct 17, 2026 | neutral | 0 | 0.6 |
| Snap (SNAP) Sees a More Significant Dip Than Broader Market: Some Facts to Know | Snap stock declined 4.81% on October 16, 2026, outpacing the broader market's 1.09% loss. Despite recent gains of 13.98% prior to this trading day, the stock faces upcoming earnings on November 4, 2026. Analysts expect strong year-over-year growth with EPS of $0.16 (up 166.67%) and revenue of $1.72 billion (up 14.33%). Snap trades at a Forward P/E of 10.98, below its industry average of 21.23, and holds a Zacks Rank #3 (Hold) rating. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | neutral | 0 | 1 |
| Snap (SNAP) officer plans to sell 6,854 shares to cover taxes on vested stock grants - Stock Titan | Snap (SNAP) officer plans to sell 6,854 shares to cover taxes on vested stock grants Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| Snap (SNAP) officer sells 42,741 shares to cover taxes on vested stock grants - Stock Titan | Snap (SNAP) officer sells 42,741 shares to cover taxes on vested stock grants Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| SNAP Stock Faces Analyst Caution And Rising Regulatory Heat - Timothy Sykes | SNAP Stock Faces Analyst Caution And Rising Regulatory Heat Timothy Sykes | View source ↗ | Timothy Sykes | Oct 16, 2026 | neutral | 0 | 0.6 |
| Snap (SNAP): 3 Reasons We Love This Stock - Yahoo Finance | Snap (SNAP): 3 Reasons We Love This Stock Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS | Robbins Geller announces a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertising platforms and charging for prescriptions immediately after intake forms despite claiming personalized consultations. The FTC filed a lawsuit on July 29, 2026, leading to a 15% decline in Hims & Hers stock. Investors with substantial losses can seek lead plaintiff status before November 2, 2026. | View source ↗ | GlobeNewswire Inc. | Oct 15, 2026 | bearish | -0.333 | 1 |
| INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS | Robbins Geller announces a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertising platforms and charging for prescriptions immediately after intake forms despite claiming personalized consultations. The FTC filed a lawsuit on July 29, 2026, leading to a 15% decline in Hims & Hers stock. Investors with substantial losses can seek lead plaintiff status before November 2, 2026. | View source ↗ | GlobeNewswire Inc. | Oct 15, 2026 | bearish | -0.333 | 1 |
| Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action | Robbins LLP is reminding investors of a pending class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' sensitive health information with advertising platforms while claiming privacy protection, and engaging in deceptive billing practices. The FTC filed a lawsuit on July 29, 2026, which caused HIMS stock to decline 14.73%. Investors who purchased securities between August 4, 2025 and July 29, 2026 may be eligible to participate, with a lead plaintiff deadline of November 2, 2026. | View source ↗ | GlobeNewswire Inc. | Oct 14, 2026 | bearish | -0.333 | 1 |
| Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action | Robbins LLP is reminding investors of a pending class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' sensitive health information with advertising platforms while claiming privacy protection, and engaging in deceptive billing practices. The FTC filed a lawsuit on July 29, 2026, which caused HIMS stock to decline 14.73%. Investors who purchased securities between August 4, 2025 and July 29, 2026 may be eligible to participate, with a lead plaintiff deadline of November 2, 2026. | View source ↗ | GlobeNewswire Inc. | Oct 14, 2026 | bearish | -0.333 | 1 |
| Here's Why Snap (SNAP) Fell More Than Broader Market | Snap (SNAP) declined 6.01% in trading, underperforming the S&P 500's 1.11% loss. The company is set to report earnings on November 4, 2026, with analysts expecting $0.16 EPS (166.67% YoY growth) and $1.72B revenue (14.33% growth). For the full year, consensus estimates project $0.59 EPS and $6.78B revenue. SNAP trades at a Forward P/E of 11.06, below the industry average of 20.8, and holds a Zacks Rank #3 (Hold) rating. | View source ↗ | Zacks Investment Research | Oct 14, 2026 | neutral | 0 | 1 |
| How to Buy Snap Stock (SNAP) in 2026 - The Motley Fool | How to Buy Snap Stock (SNAP) in 2026 The Motley Fool | View source ↗ | The Motley Fool | Oct 14, 2026 | neutral | 0 | 0.6 |
| Snap CEO Bets Big On Subscription Revenue Runway After Q2 Beat Sends Stock Soaring: ‘Substantial Room To Grow’ - Stocktwits | Snap CEO Bets Big On Subscription Revenue Runway After Q2 Beat Sends Stock Soaring: ‘Substantial Room To Grow’ Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| Snap stock breaks six-day winning streak - TradingView | Snap stock breaks six-day winning streak TradingView | View source ↗ | TradingView | Oct 13, 2026 | neutral | 0 | 0.6 |
| Social Media Stocks Rally as Truist Sets $1,000 Street-High Meta Target on Muse Adoption: Meta and Snap Climb 4%, Reddit Ticks Up - 24/7 Wall St. | Social Media Stocks Rally as Truist Sets $1,000 Street-High Meta Target on Muse Adoption: Meta and Snap Climb 4%, Reddit Ticks Up 24/7 Wall St. | View source ↗ | 24/7 Wall St. | Oct 13, 2026 | neutral | 0 | 0.6 |
| A 6-Day Winning Streak Has Snap Stock Up 17% - Trefis | A 6-Day Winning Streak Has Snap Stock Up 17% Trefis | View source ↗ | Trefis | Oct 13, 2026 | neutral | 0 | 0.6 |
| SNAP Stock Gains On Q2 Beat, Splitting Wall Street Between ‘Solid Footing’ And ‘Too Early’ To Call A Turn - Stocktwits | SNAP Stock Gains On Q2 Beat, Splitting Wall Street Between ‘Solid Footing’ And ‘Too Early’ To Call A Turn Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| SNAP Stock Pops As SPECS AR Glasses And AI Bets Grow - StocksToTrade | SNAP Stock Pops As SPECS AR Glasses And AI Bets Grow StocksToTrade | View source ↗ | StocksToTrade | Oct 12, 2026 | neutral | 0 | 0.6 |
| Snap Stock Eyes Repricing As AR Specs And Activists Step In - Timothy Sykes | Snap Stock Eyes Repricing As AR Specs And Activists Step In Timothy Sykes | View source ↗ | Timothy Sykes | Oct 12, 2026 | neutral | 0 | 0.6 |
| A massive trade just happened in surging shares of Snap - CNBC | A massive trade just happened in surging shares of Snap CNBC | View source ↗ | CNBC | Oct 12, 2026 | neutral | 0 | 0.6 |
| Unusual Call Options Activity in SNAP Stock - Investors Turning Bullish? - Barchart.com | Unusual Call Options Activity in SNAP Stock - Investors Turning Bullish? Barchart.com | View source ↗ | Barchart.com | Oct 12, 2026 | neutral | 0 | 0.6 |
| Snap Stock In Focus Ahead Of Earnings And Specs Stake Sale Talk - Simply Wall Street | Snap Stock In Focus Ahead Of Earnings And Specs Stake Sale Talk Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - HBSS | Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company deceptively shared consumers' health data with third-party advertising platforms like Meta and Snap, and violated billing regulations by charging for prescriptions before medical consultations. The stock plunged 14.7% on July 29, 2026, erasing over $970 million in market value. | View source ↗ | GlobeNewswire Inc. | Oct 9, 2026 | bearish | -0.333 | 1 |
| What's Going On With Snap Stock Friday? - Benzinga | What's Going On With Snap Stock Friday? Benzinga | View source ↗ | Benzinga | Oct 9, 2026 | neutral | 0 | 0.6 |
| Snap Inc. (SNAP) Stock Forecasts - Yahoo! Finance Canada | Snap Inc. (SNAP) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| 1 MONTH INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS | Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement. | View source ↗ | GlobeNewswire Inc. | Oct 2, 2026 | bearish | -1 | 1 |
| 1 MONTH INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS | Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement. | View source ↗ | GlobeNewswire Inc. | Oct 2, 2026 | bearish | -1 | 1 |
| SNAP: Priced Like A Decline, Paying Like A Machine - Trefis | SNAP: Priced Like A Decline, Paying Like A Machine Trefis | View source ↗ | Trefis | Aug 25, 2026 | neutral | 0 | 0.6 |
| SNAP Stock Is ‘Easiest 5-10x’ Out There, Says Scott Galloway — But CEO Needs To 'Wake Up From Decade-Long Hallucination' - TradingView | SNAP Stock Is ‘Easiest 5-10x’ Out There, Says Scott Galloway — But CEO Needs To 'Wake Up From Decade-Long Hallucination' TradingView | View source ↗ | TradingView | Aug 11, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.